Circulating T-cell receptor diversity as predictive biomarker for PARP inhibitors maintenance therapy in high grade serous ovarian cancer
Circulating T-cell receptor diversity as predictive biomarker for PARP inhibitors maintenance therapy in high grade serous ovarian cancer
复制标题
DOI：
10.1016/j.ygyno.2022.11.013
复制
发表时间：
2022
影响因子：
4.7
通讯作者：
Hong Zheng
中科院分区：
文献类型：
--
作者：
Tong Shu;Zhipeng Zhou;Jing Bai;Xiao Xiao;Min Gao;Nan Zhang;Hongguo Wang;Xuefeng Xia;Yunong Gao;Hong Zheng
